The phytosterols market has seen considerable growth due to a variety of factors.
•In the past few years, the phytosterols market has seen swift growth. The market is projected to grow from $1.1 billion in 2024 to $1.22 billion in 2025, with a compound annual growth rate (CAGR) of 10.3%.
The considerable growth in the historical period can be ascribed to factors such as increased health awareness, a rise in cardiovascular diseases, trends in functional food and nutraceuticals, government actions to fight obesity, and the use of functional ingredients in cosmetics.
The phytosterols market is expected to maintain its strong growth trajectory in upcoming years.
• Anticipations for a swift expansion of the phytosterols market size in the upcoming years have been made. The market should proliferate to $1.91 billion by 2029, with a compound annual growth rate (CAGR) of 11.8%.
The forecast period's growth is linked to factors like the popularization of plant-based diets, exploration of additional health benefits, the rise of functional beverages, regulatory backing for health claims, and the worldwide aging population. The market trends expected during this forecast period involve innovations in delivery methods, cooperation in research and development, personalized nutrition using phytosterols, clean labeling transparency, and the use of phytosterols in pet food.
The escalation of cardiovascular disease is substantially supporting the expansion of the phytosterols market moving forward. Cardiovascular disease, an overarching phrase that represents conditions impacting the heart or blood vessels, includes coronary heart disease, stroke, peripheral arterial disease, aortic disease, and others. Competing with cholesterol absorption by binding to micelles thus reducing cholesterol concentration, plant sterols, or phytosterols, are known. A decrease in LDL cholesterol levels by about 8% to 10% has been associated with a daily ingestion of phytosterols. For example, it was determined by the British Heart Foundation in September 2024 that around 7.6 million individuals in the UK are impacted by heart and circulatory diseases, which includes around 4 million men and 3.6 million women. These diseases account for around 27% of total deaths in the UK, equating to more than 170,000 individuals per year, or an estimated 480 deaths per day, which equates to a death every three minutes. Hence, the mounting prevalence of cardiovascular disease is fuelling the growth of the phytosterols market.
The phytosterols market covered in this report is segmented –
1) By Type: Beta-Sitosterols, Campesterols, Stigmasterols, Other Types
2) By Source: Vegetable Oils, Nuts and Seeds, Whole Grains, Other Sources
3) By Form: Dry, Liquid
4) By Application: Food And Beverages, Pharmaceuticals, Cosmetics, Dietary Supplements, Animal Feed
Subsegments:
1) By Beta-Sitosterols: Beta-Sitosterol Esters, Free Beta-Sitosterol
2) By Campesterols: Campesterol Esters, Free Campesterol
3) By Stigmasterols: Stigmasterol Esters, Free Stigmasterol
4) By Other Types: Brassicasterol, Ergosterol
Product innovation is emerging as a predominant trend in the phytosterols market. As part of a strategic approach to maintaining market dominance, leading firms in the phytosterols market are concentrating their efforts on the creation and deployment of new products and resolutions. Case in point, in May 2023, ProBiotix Health PLC, a UK-based firm specializing in the life sciences, introduced an inventive dual-action bi-layer tablet for cholesterol reduction known as CholBiome CH. The tablet features two main ingredients - Lactobacillus plantarum LPLDL and plant sterols/stanols (PSS), which work in tandem to support the cholesterol-reducing dual-action formula's aim of moderating both internal and dietary cholesterol. Promoting a two-pronged action, the new, allergy-free and non-GMO innovation utilises award-winning element LPLDL to act upon internal cholesterol, prompting the production of enzymes to disassemble bile salts. This stimulates the liver to expel cholesterol from the bloodstream, thus maintaining required levels and ensuring the body's bile salt pool remains healthy.
Major companies operating in the phytosterols market include:
• Cargill Inc.
• Archer Daniels Midland Company
• BASF SE
• Wilmar International Limited
• Bunge Limited
• Unilever PLC
• Sigma-Aldrich Company LLC
• Ashland Global Holdings Inc.
• Evonik Industries AG
• ProBiotix Health Ltd
• Raisio PLC
• Les Dérives Résiniques Et Terpéniques SA (DRT)
• Avanti Polar Lipids Inc
• Xi'an Healthful Biotechnology Co. Ltd.
• Matrix Life Science Pvt. Ltd.
• Connoils LLC
• Arboris LLC
• Advanced Organic Materials SA
• BOC Sciences
• Foodchem International Corporation
• Lipofoods SLU
• Vitae Naturals
• Herbo Nutra Extract Private Limited
• CD Bioparticles
• Ipsum Lifesciences LLP
• MMP Inc.
• Gustav Parmentier GmbH
• Hyphyto Inc.
• Enzymotech Ltd.
• Tama Biochemical Co.Ltd.
Europe was the largest region in the phytosterols market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the phytosterols market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.